Dynamin-like guanylate binding proteins (GBPs) are gamma interferon (IFN)-inducible host defense proteins that can associate with cytosol-invading bacterial pathogens. Mouse GBPs promote the lytic destruction of targeted bacteria in the host cell cytosol but the antimicrobial function of human GBPs and the mechanism by which these proteins associate with cytosolic bacteria are poorly understood. Here, we demonstrate that human GBP1 is unique amongst the seven human GBP paralogs in its ability to associate with at least two cytosolic Gram-negative bacteria, Burkholderia thailandensis and Shigella flexneri. Rough lipopolysaccharide (LPS) mutants of S. flexneri co-localize with GBP1 less frequently than wildtype S. flexneri, suggesting that host recognition of O-antigen promotes GBP1 targeting to Gram-negative bacteria. The targeting of GBP1 to cytosolic bacteria, via a unique triple-arginine motif present in its C-terminus, promotes the co-recruitment of four additional GBP paralogs (GBP2, GBP3, GBP4 and GBP6). GBP1-decorated Shigella replicate but fail to form actin tails leading to their intracellular aggregation. Consequentially, wildtype but not the triple-arginine GBP1 mutant restricts S. flexneri cell-to-cell spread. Furthermore, human-adapted S. flexneri, through the action of one its secreted effectors, IpaH9.8, is more resistant to GBP1 targeting than the non-human-adapted bacillus B. thailandensis. These studies reveal that human GBP1 uniquely functions as an intracellular 'glue trap' inhibiting the cytosolic movement of normally actin-propelled Gram-negative bacteria. In response to this powerful human defense program S. flexneri has evolved an effective counterdefense to restrict GBP1 recruitment.
Introduction
Cell-autonomous immunity describes the ability of a single cell to defend itself against intracellular pathogens and constitutes an essential branch of the immune system (1, 2) . Cellautonomous immunity in vertebrates is often orchestrated by IFN-inducible genes (ISGs) (2) .
Amongst the most robustly expressed ISGs are those encoding dynamin-like guanylate binding proteins (GBPs) (3) (4) (5) . GBPs control intrinsic antiviral, antiprotozoan and antibacterial immunity, are highly expressed in inflamed tissue, and can be predictive of infectious disease progressions (5) (6) (7) (8) (9) (10) . Since their discovery, seven human GBP orthologs and one pseudogene have been identified. The GBP genes are located within one gene cluster on chromosome 1 (11) . Other vertebrate genomes contain comparable numbers of GBP orthologs: e.g. mice possess 11 genes in addition to 2 pseudogenes (12) . Human and mouse GBPs share a high degree of homology with the most conserved region found within their N-terminal G domains. However, GBP protein family members are highly divergent from each other at their very C-terminal ends, both within and across different vertebrate species (11) . The functional consequence of this C-terminal amino acid sequence variability has not been previously explored.
To exert many of their anti-microbial functions, GBPs specifically associate with intracellular microbes residing in the host cell cytosol or at pathogen-occupied supramolecular structures, which include viral replication complexes (10) and pathogen-containing vacuoles (3) (4) (5) . Following pathogen recognition, GBPs are thought to deliver antimicrobial host factors to pathogencontaining vacuoles and to bacteria residing in the host cell cytosol, thereby enabling the execution of distinct defense pathways which include membranolytic destruction of cytosolic bacteria (13, 14) , capture of microbes within degradative autolysosomes (7) , and activation of inflammasomes (13) (14) (15) (16) (17) (18) (19) . These studies clearly demonstrated the importance of GBPs in host defense against a broad spectrum of pathogens in a vertebrate host. However, because these previous studies were conducted almost exclusively in mouse models, it remains to be determined whether human GBPs execute functions comparable to their murine counterparts.
In this study we systematically tested all seven members of the human GBP protein family for their ability to co-localize with the cytosolic bacterial pathogens Listeria monocytogenes, Shigella flexneri and Burkholderia thailandensis. All of these bacterial species are equipped with the ability to co-opt the host actin polymerization machinery for actin-based cytosolic motility and cell-to-cell spread (20) . While we failed to detect any co-localization between human GBPs and the Grampositive bacterium, L. monocytogenes, we found that GBP1, independent of other human GBP paralogs, targeted both Gram-negative bacteria, B. thailandensis and S. flexneri. This specific interaction between GBP1 and bacteria, which is determined by a unique C-terminal triple-arginine motif, inhibits actin-tail formation of GBP1-decorated bacteria resulting in a reduction of bacterial cell-to-cell spread. We further observed that GBP1 targeted the non-human-adapted microbe B. thailandensis more efficiently than the human-adapted pathogen S. flexneri and identified the bacterial ubiquitin E3 ligase IpaH9.8 as a S. flexneri virulence factor that interferes with GBP1 recruitment to this professional cytosolic bacterium. Thus, this study provides a novel understanding of the role of human GBPs in immunity to bacterial pathogens and also defines a virulence strategy employed by a human-adapted microbe to escape from GBP1-regulated host defense.
Results

Human GBP1 co-localizes with cytosolic S. flexneri and B. thailandensis
Most known GBP-mediated antimicrobial functions require that GBPs directly localize to intracellular microbes or their surrounding vacuoles (3) (4) (5) . Based on this premise we screened the entire set of human GBPs (GBP1 -7) as ectopically expressed mCherry N-terminal fusion proteins in the human epithelial lung carcinoma cell line A549 for co-localization with the cytosolic bacterial pathogen S. flexneri. Expression of each fusion protein was detectable by Western blotting ( Figure   S1 ) and by immunofluorescence ( Figure 1A) . Unexpectedly, only a single member, GBP1, associated with cytosolic S. flexneri, as assessed at 1 and 3 hours post infection (hpi) in either naïve or IFN-primed A549 cells ( Figure 1A ). Association of GBP1 with individual S. flexneri bacteria was observed as early as 10 minutes post host cell invasion (data not shown and video S1). Similarly, we observed that GBP1 was the sole human GBP family member to co-localize with B. thailandensis, another cytosolic Gram-negative pathogen ( Figure 1B) . In contrast to the observed targeting of GBP1 to these Gram-negative bacteria, we failed to detect any colocalization with L. monocytogenes, a cytosolic Gram-positive pathogen ( Figure 1C ).
Targeting of GBP1 to S. flexneri is dependent on its functional G domain, CaaX box and a Cterminal triple-arginine motif
To determine which protein motifs and properties of GBP1 ( Figure 2A ) render it uniquely capable to detect cytosolic Gram-negative bacteria, we generated and screened a large set of GBP1 mutant variants for co-localization with cytosolic S. flexneri. Mutant variants previously established to be defective for GTP hydrolysis (GBP1 R48A ) or nucleotide binding (GBP1 K51A and GBP1 S52N ) (21, 22) failed to associate with S. flexneri ( Figure 2B ). These findings were expected, because GTP binding and hydrolysis are required for GBP1 dimerization, protein polymerization and membrane binding (21) (22) (23) (24) (25) (26) . We also found that targeting to S. flexneri was dependent on the C-terminal CaaX box of GBP1 ( Figure 2B ). This finding was also expected as CaaX boxdependent prenylation of GBP1 provides a lipid anchor critical for the membrane association of GBP1 (25) (26) (27) .
Both GBP1 and GBP2 contain highly homologous N-terminal G domains and carry Cterminal CaaX boxes (11) , yet only GBP1 efficiently associates with S. flexneri in A549 cells ( Figure 1A ). We therefore generated protein chimeras between GBP1 and GBP2 to map the motif that uniquely directs GBP1 to cytosolic bacteria. Most of the divergence between GBP1 and GBP2 sequences is found within the C-terminal subdomain (CTSD) consisting of -helices 12 and 13, a short flexible region, and the CaaX box. We therefore swapped the CTSDs of GBP1 and GBP2 to generate two complementary chimeric proteins and found that the GBP1-but not GBP2-derived CTSD determined protein targeting to S. flexneri ( Figure 2C ). Swapping the CaaX boxes on the other hand only moderately reduced GBP1 targeting to bacteria ( Figure 2C ), indicating the existence of an additional motif within the GBP1-CTSD critical for bacterial recognition. Within the flexible region of CTSD we identified a GBP1-specific poly-basic protein motif (PBM), a 6 amino acid stretch containing 5 basic residues (KMRRRK). Deletion of these 6 residues or mutation of the triple-arginine cassette to triple-alanine abrogated co-localization of GBP1 with S. flexneri ( Figure   2C ). In a complementary approach, we found that insertion of the GBP1-PBM between GBP2 residues 586 and 587 (GBP2 +PBM ) was sufficient to drive significant targeting of GBP2 to S. flexneri ( Figure 2C ). Swapping the GBP2 with the GBP1 CaaX box further improved the bacteria-targeting efficiency such that GBP2 +PBM+GBP1-CaaX is recruited to Shigella at levels comparable to wildtype GBP1 ( Figure 2D ). These data demonstrate that a triple-arginine motif within the C-terminal PBM of GBP1 is essential and sufficient to equip both GBP1 and GBP2 with the ability to detect cytosolic S. flexneri, while the GBP1 CaaX box further improves targeting efficiency.
Triple-arginine motif controls delivery of GBP1 to sterilely damaged vacuoles.
To identify possible molecular targets for the C-terminal PBM of GBP1, we followed up on our previous published observation that GBP1 but none of its human paralogs detect sterilely damaged endogenous vacuoles in human embryonic kidney (HEK) 293T cells (28) . The disruption of vacuoles leads to the cytosolic exposure of glycans that are normally confined to the vacuolar lumen. These exposed sugars then prompt the recruitment of the -galactoside-binding lectin Galectin-3 as an established marker for loss of vacuolar integrity (29) . To determine whether the PBM of GBP1 could promote the recognition of glycans, we tested its role in the delivery of GBP1 to ruptured vesicles. We first determined whether the structural requirements for the delivery of GBP1 to ruptured endosomes generally resembled those for the targeting of GBP1 to bacteria. In support of this premise, we observed that delivery of GBP1 to damaged endosomes was dependent on its functional G domain and CaaX box ( Figure 3A ). We further noticed that the CTSD of GBP1 was essential for the delivery of GBP1, and sufficient to promote recruitment of chimeric GBP2 protein, to damaged vesicles ( Figure 3B ). Deletion of PBM or mutation of the triplearginine motif led to substantially reduced co-localization between Galectin-3-marked vacuoles and GBP1 ( Figure 3B ), indicating a functional role for the triple-arginine motif in the delivery of GBP1 to disrupted vesicles. These observations suggested that the triple-arginine motif of GBP1 directly or indirectly detects glycans.
S. flexneri mutants lacking O-antigen are targeted infrequently by GBP1
Because GBP1 detects broken vacuoles that are marked by cytosolically exposed polysaccharides normally confined to the vacuolar lumen, we speculated that bacterial surface-exposed polysaccharides could similarly underlie the recruitment of GBP1 to S. flexneri. We thus investigated whether GBP1 either directly or indirectly detects lipopolysaccharide (LPS), the main building block of Gram-negative bacterial envelope. Because O-antigen forms the outward sugar portion of LPS on the surface of bacteria, we tested GBP1 recruitment to the O-antigen-deficient galU and rfaL 'rough' S. flexneri mutants, which enter the host cell cytosol of non-polarized epithelial cells at comparable frequencies (30) . We found that co-localization of ectopically expressed ( Figure 4C ) or endogenous GBP1 ( Figure 4C ) to S. flexneri rough mutants was substantially diminished relative to GBP1 targeting to wildtype S. flexneri, indicating that O-antigen recognition plays an important role in GBP1 recognition of cytosolic Gram-negative bacteria.
We previously demonstrated that Galectin-3 interacts with a subset of murine GBPs and promotes their recruitment to Legionella-as well as Yersinia-containing vacuoles (28) . Because Galectin-3 binds to O-antigen as well as the inner core of LPS (31), we hypothesized that Galectin-3 could promote the delivery of GBP1 to the Gram-negative bacterium S. flexneri. However, we observed that ectopically expressed GBP1 co-localized with S. flexneri with comparable frequencies in wildtype and Galectin-3 deficient mouse embryonic fibroblasts (MEFs) ( Figure S2 ). Together, these data suggest GBP1 detects cytosolic S. flexneri in an O-antigen-dependent but Galectin-3independent manner.
GBP1-decorated S. flexneri replicate within intracellular bacterial clusters
Previous work demonstrated the lytic destruction of GBP-bound cytosolic bacteria in mouse cells (13, 14) . To assess whether recruitment of human GBP1 to S. flexneri would similarly drive bactericidal effects, we used an IPTG-inducible GFP reporter system as a bacterial viability indicator. In these experiments, we infected HeLa cells with reporter-positive S. flexneri, then induced GFP expression with IPTG at 2 hpi and stained cells for endogenous GBP1 and LPS at 4 hpi ( Figure 5A ). As expected, inhibition of bacterial translation with chloramphenicol treatment at 2 hpi blocked detectable GFP expression at 4hpi ( Figure 5B ), thus validating the reporter system. In the absence of chloramphenicol, GBP1-targeted and -untargeted bacteria were GFP-positive at comparable frequencies, indicating that GBP1 recruitment to S. flexneri fails to promote bacterial killing at this time point ( Figure 5B ). Instead, we noticed that GBP1-positive bacteria form intracellular clusters. To determine whether GBP1 could be responsible for this clustering effect, we generated HeLa cells that lack GBP1 (GBP1 KO ) ( Figure 5C ). Following IFN priming to induce expression of GBPs, we observed reduced bacterial clustering in two independent GBP1 KO clonal cell lines as compared to the parental HeLa cells ( Figure 5D ). Bacterial clustering was restored in GBP1 KO cells by ectopically expressing wildtype GBP1 but not a triple-arginine mutant ( Figure 5D ). Furthermore, we found that GBP1-decorated, clustered bacteria not only remained viable but continued to divide ( Figure 5E and video S2). Thus, our observations indicate that triple-argininedependent delivery of GBP1 to cytosolic S. flexneri promotes bacterial clustering but fails to execute bactericidal or bacteriostatic activities.
GBP1 inhibits actin-based motility in a triple-arginine motif-dependent manner
GBP1-decorated S. flexneri cluster intracellularly and therefore phenocopy S. flexneri icsA mutants ( Figure 6A ) that lack the ability to form actin tails and hence are non-motile inside the host cell cytosol (32) . Thus, we hypothesized that GBP1 blocks S. flexneri actin tail formation. In support of this hypothesis we observed a marked reduction in actin tails associated with GBP1tagged versus -untagged S. flexneri in 293T cells expressing mCherry-GBP1 ( Figure 6A ). To complement these GBP1 overexpression studies, we scored actin tail-positive bacteria in wildtype versus GBP1 KO HeLa cells. We found that IFN priming reduced the number of bacteria with actin tails in wildtype but not in GBP1 KO cells ( Figure 6B ). Complementation of GBP1 KO cells with wildtype GBP1 but not the triple-arginine mutant (GBP1 R584-586A ) dramatically reduced the number of actin tail-positive bacteria to levels observed in IFN-primed wildtype cells ( Figure 6B ). As expected, GBP1-mediated inhibition of actin tail formation correlated with a GBP1-mediated block in cell-to-cell spread ( Figure 6C ). Inhibition of cell-to-cell spread was restored in GBP1 KO cells complemented with wildtype but not the triple-arginine mutant (GBP1 R584-586A ) ( Figure 6D ), indicating that GBP1 targeting to bacteria is required for inhibition of bacterial cell-to-cell spread.
Endogenous GBP1 associates with S. flexneri and recruits additional GBP paralogs in HeLa but not in A549 cells
GBP1 frequently forms heterodimers with other members of the GBP family such as GBP2 (3) (4) (5) .
To determine whether GBP1 recruits other GBP paralogs to cytosolic S. flexneri, we ectopically expressed mCherry-tagged human GBP1-7 in wildtype and GBP1 KO HeLa cells and monitored for subcellular localization of each with cytosolic S. flexneri. We found that ectopically expressed GBP2, and to a lesser extent GBP3, GBP4 and GBP6 co-localized with S. flexneri in HeLa cells in a GBP1-dependent manner ( Figure 7A ). This finding was curious, as we had not observed any colocalization of these GBP paralogs with S. flexneri in wildtype A549 cells ( Figure 1A ). We therefore monitored the subcellular localization of endogenous GBP1 in A549 cells and found that endogenous GBP1 targeted S. flexneri in HeLa but not in A549 cells ( Figure 7B ), which correlated with reduced expression of GBP1 protein in A549 compared to HeLa cells ( Figure 7C ). While endogenous GBP1 failed to decorate S. flexneri in A549 cells, we noticed that in the same cell line about 40% of cytosolic B. thailandensis stained positive for endogenous GBP1 ( Figure 7B ). These data suggested that B. thailandensis is more susceptible to GBP1 targeting than S. flexneri. To test this hypothesis, we generated a titratable, i.e. anhydrotetracycline (aTc)-inducible expression system for GBP1 ( Figure 7D ). As expected, higher GBP1 expression levels promoted more frequent co-localization with either bacterium. However, the overall frequency of GBP1 colocalization was significantly higher for B. thailandensis than for S. flexneri ( Figure 7E ). These data indicated that S. flexneri is more resistant to GBP1 targeting than B. thailandensis and therefore suggested that S. flexneri actively interferes with cytosolic detection by GBP1.
IpaH9.8 blocks GBP1 recruitment and GBP1-mediated inhibition of actin-based motility
To account for our observations, we hypothesized that an effector secreted by the Shigella type 3 secretion system (T3SS) interferes with GBP1 targeting to cytosolic bacteria. To test this hypothesis, we monitored co-localization of GBP1 with two S. flexneri mutants deficient for the secretion of distinct subsets of type III effectors. A bacterial mutant lacking Spa15, the chaperone required for the secretion of the effectors IpaA, IpgB1, IpgB2, OspB, OspC1, OspC2, OspC3, OspD1 and OspD2 (33) (34) (35) (36) , was targeted with the same efficiency as wildtype S. flexneri ( Figure   8A ). However, mxiE Shigella, a strain lacking the transcription factor that controls expression of second phase S. flexneri effectors including all IpaH effectors as well as OspB, OspC1, OspE1, OspE2, OspF, OspG and VirA (37-39), co-localized more frequently with GBP1 than wildtype S. flexneri in both A549 and HeLa cells ( Figure 8A ). These findings indicated that one or more mxiE-dependent T3SS effectors interfered with GBP1 function. To identify this virulence factor, we screened S. flexneri mutants deficient in individual mxiE-dependent T3SS effectors encoded on the S. flexneri virulence plasmid and found that ipaH9.8 mimicked the mxiE phenotype ( Figure   8B ). Further, we found that ipaH9.8 was deficient for cell-to-cell spread in parental HeLa but not in GBP1 KO cells ( Figure 8C ), indicating that IpaH9.8-mediated interference with GBP1 targeting is critical for S. flexneri dissemination throughout the colonic epithelium. Cell-to-cell spread of the mxiE mutant compared to wildtype S. flexneri was still moderately diminished in GBP1 KO cells, suggesting that one or more additional mxiE-controlled effectors other than ipaH9.8 promote cellular dissemination ( Figure 8C ).
Discussion
Many cell-autonomous defense mechanisms depend on the ability of the host cell to detect the precise location of an intracellular microbe inside an infected host cell (40) . Pathogen-containing vacuoles are targeted by GBPs following immune recognition through missing-self or aberrant-self mechanisms (28, 41, 42) , but the mechanism by which GBPs detect cytosolic pathogens had not previously been investigated. Here, we demonstrate that human GBP1 contains a unique triplearginine motif within its flexible C-terminal region, which mediates the delivery of GBP1 to the Gram-negative cytosolic pathogen S. flexneri. We also demonstrate in this study that S. flexneri rough mutants lacking LPS O-antigen are targeted less efficiently by GBP1 than the co-isogenic wildtype strain. These observations suggest that the triple-arginine motif of human GBP1 either directly or indirectly interacts with the polysaccharide portion of LPS on the bacterial surface.
GBP1 binding to bacteria still occurs in the absence of O-antigen, albeit less efficiently. One possible explanation for this observation is that GBP1 associates with LPS through two or more distinct interactions, as has been described for Galectin-3. Galectin-3 binds to LPS through a highaffinity interaction with O-antigen as well as a low-affinity interaction with the inner LPS core (31) .
Alternatively, GBP1 could be recruited to bacteria through an additional LPS-independent mechanism. Future in vitro binding studies are required to test whether GBP1 binds to Gramnegative bacteria directly or indirectly, and to identify the specific binding substrate(s) or interaction partner(s) of the C-terminal triple-arginine motif essential for immune targeting of cytosolic S. flexneri by GBP1.
Previous work demonstrated that deposition of murine GBP2 on the cytosolic bacterial pathogen Francisella novicida results in bacteriolysis (13, 14) . Similarly, murine GBPs also promote the lytic destruction of S. flexneri (43) . Unexpectedly, we found that the delivery of human GBP1 to cytosolic S. flexneri is insufficient to kill bacteria or halt their replication. Instead, we observed that GBP1-bound bacteria fail to form actin tails and are consequentially restricted for efficient cell-to-cell spread. These observations were confirmed by an independent report published during the preparation of our manuscript (44) . The differences between mouse and human in regards to the consequences of GBP targeting are intriguing and warrant future investigations to determine, for instance, whether the lytic pathway present in mouse cells is absent from human cells. The latter model is supported by a report demonstrating that GBPdependent recruitment of the IFN-inducible GTPases Irgb10 to cytosolic F. novicida is required for bacteriolysis in mouse cells (45) . Importantly, genes encoding Irgb10 and its paralogous subset of immunity related GTPases (IRGs) with a canonical GxxxxGKS P-loop sequence are absent from the human genome (46, 47) , potentially accounting for the absence of an intracellular bacteriolytic pathway in human cells.
The dysregulation of cell-autonomous defense programs by S. flexneri is paramount to the microbes' ability to colonize its human host and establish an infection (48) . In agreement with two studies published during the preparation of our manuscript (43, 44) , we found that the translocated bacterial ubiquitin E3 ligase IpaH9.8 inhibits the association of GBP1 with cytosolic S. flexneri in human cells. We did not investigate the mechanism by which IpaH9.8 interferes with GBP1 localization to bacteria, but the aforementioned studies demonstrated that IpaH9.8 ubiquitinates GBP1 and promotes its degradation via the proteasome (43, 44) . While proteolytic degradation was clearly demonstrated at infections with high multiplicity of infection (MOI) or in cells ectopically expressing IpaH9.8 (43, 44) , we failed to observe a pronounced decrease in GBP1 protein expression in cells infected with S.flexneri under the infection conditions used in our studies ( Figure 7C ). Furthermore, video microscopy data suggest that GBP1 ubiquitination by IpaH9.8 helps to dislodge GBP1 from targeted bacteria (44) . We therefore propose that ubiquitination by IpaH9.8 not only tags GBP1 for proteolytic degradation but also directly blocks binding of GBP1 to bacteria and/or removes GBP1 from already targeted bacteria. Importantly, Li et al. demonstrated that IpaH9.8 promotes poly-ubiquitination of the GBP1 residues K582 and K587 (43) , which flank the triple-arginine motif essential for recruiting GBP1 to S. flexneri. Whether PBM ubiquitination blocks GBP1 binding to bacteria through steric hindrance will be investigated in future studies.
Materials and Methods
Cell Lines and Culture
Primary WT and Galectin-3 KO (49) MEFs were made from C57BL/6J background mice acquired from the Jackson Laboratory. MEFs, A549, 293T, and HeLa cells were maintained at 37 and 5% CO2 in DMEM supplemented with 10% heat inactivated fetal bovine serum, nonessential amino acids (Gibco), and 55 M -mercaptoethanol. GBP1 KO lines were derived from HeLa-Cas9 cells, which contains a stably integrated Cas9 expression vector, lentiCas9-Blast (50) . HeLa-Cas9 cells were transiently transfected with two guide RNAs directed against exon 6, GBP1-2 (TTGATCGGCCCGTTCACCGC) and GBP1-3 (TCCGGATACAGAGTCTGGGC), to introduce a predicted 64 bp deletion. Single clones were isolated by dilution. Resulting alleles are described in Table S1 . All instances of IFN priming were done overnight at 200 U/ml.
Bacterial Strains and Infections
Bacterial strains are summarized in Table S2 . 2457T S.flexneri-derived ∆mxiE, ∆ospB, ∆ospC1, ∆virA, ∆IpaH1.4, ∆IpaH4.5, ∆IpaH7.8 and ∆IpaH9.8 were constructed using the  red recombinasemediated recombination system (51) using DNA oligomers listed in Table S3 . GFP + S.flexneri stains contain the vector pGFPmut2 (52) . The IPTG-inducible GFP vector pRK2-IPTG-GFP was a gift from Wendy Picking. S.flexneri was grown at 37 on tryptic soy agar plates containing 0.01% Congo Red, as well as 50 µg/ml carbenicillin for pGFPmut2 and PRK2-IPTG-GFP containing strains. For infections, 5 ml tryptic soy broth (TSB) was inoculated with a single Congo red-positive colony and grown overnight at 37 with shaking. Saturated cultures were diluted 1:50 in 5 ml fresh TSB and incubated for 2.5-3 h at 37 with shaking. Bacteria were diluted in pre-warmed cell culture medium, and spun onto cells for 10 minutes at 700 x g. Plates were incubated at 37 for 30 minutes, then washed twice with Hanks Balanced Salt Solution (HBSS), followed by addition of cell culture medium containing 25 µg/ml gentamicin and further incubation at 37. Unless otherwise specified, cells were infected at an MOI of 50. For time lapse microscopy and plaque assays, 5x10 7 bacteria were harvested by centrifugation and incubated in 1 ml phosphate buffered saline (PBS) containing 5 g/ml poly-D-lysine at 37 for 15 minutes with shaking, as described (53) . Poly-D-lysine pre-treated bacteria were then used for infection, as above. B. thailandensis wiltype strain E264 carrying a GFP-expression construct was a gift from Edward Miao. B.thailandensis +GFP was grown at 37 on LB plates containing 100 ug/ml trimethoprim. For infections, overnight cultures were diluted 1:20 in LB + trimethoprim and grown for 3 h at 37 with shaking. Cells were infected at an MOI of 100, as above. Infected plates were incubated at 37 for 2.5 h, washed twice with HBSS, and incubated in the presence of 30 g/ml kanamycin for 2 h. Kanamycin containing medium was then replaced with medium without antibiotics, and plates were incubated at 37 to 8 hpi. GFP + wildtype L. monocytogenes strain 10403S was previously described (54) and grown at 37 on brain heart infusion (BHI) plates containing 10 µg/ml streptomycin and 7.5 µg/ml chloramphenicol. Infections were carried out in an identical manner to S.flexneri using saturated overnight cultures grown at 37 with shaking. Cells were infected with L. monocytogenes at an MOI of 5.
Design of GBP Expression Constructs
Vectors containing mCherry-tagged constructs are derivatives of pmCherry-C1 (Clontech), and were constructed using DNA oligomers and restriction endonucleases listed in Table S4 . For the chimeric constructs, GBP1/2 CTSD and GBP2/1 CTSD , two synonymous mutations were introduced into GBP1 codons 478 and 479 of pmCherry-GBP1 using Quickchange site directed mutagenesis with GBP1-BclI oligomers (Table S5 ). These mutations introduced a BclI restriction endonuclease site within the sequence encoding the flexible region between helices 11 and 12. Following propagation of pmCherry-GBP1 BclI and pmCherry-GBP2 in dam -/dcm -E.coli (New England Biolabs), BclI digestion and T4 Ligase-dependent repair was used to exchange the fragment encoding the C-terminal regions of the two proteins. All other mCherry-tagged chimeric and mutant constructs were constructed using Quickchange site directed mutagenesis with the primers listed in Table S5 . GBP2 +PBM+GBP1-CaaX was constructed stepwise from pmCherry-GBP2 +PBM mutated with GBP2/1 CaaX -and then GBP2 I587A -oligomers. Tetracycline-inducible GBP1 was constructed by inserted the GBP1 ORF into the third generation Tet-On vector, pInducer20 (55), using Gateway Cloning Technology with GBP1-attB oligomers listed in Table S5 . GBP1 R584-586A was constructed by mutating the entry vector, pDONR221-GBP1, via Quickchange SDM using GBP1 R584-586Aoligomers prior to Gateway LR reactions.
Immunofluorescence Microscopy, actin tail analysis, Time-Lapse Microscopy and CPP assays
For standard microscopy cells were fixed in 4% paraformaldehyde and permeabilized with 0.25% transiently transfected with mCherry-tagged GBP constructs, as described in (28) . Calcium phosphate precipitate (CPP) assays were carried out in 293T cells stably expressing YFP-Galectin-3 and transiently transfected with mCherry-tagged GBP constructs, as described in (28) .
IPTG-Inducible GFP Viability Assay
HeLa cells were stimulated overnight with 200 U/ml IFN and infected with S.flexneri containing the IPTG-inducible GFP vector, pRK2-IPTG-GFP. At 2 hpi, IPTG was added to a concentration of 1mM. Chloramphenicol was also added to a concentration of 60 µg/ml for negative controls.
Coverslips were incubated for an additional 2 h before being fixed and stained with anti-LPS and anti-GBP1 antibodies, as described above.
S.flexneri Cluster Analysis
Images were thresholded to remove background signal, and were subjected to connexity analysis to identify adjacent structures using the 3D objects counter in FIJI. Briefly, this process takes a pixel of interest and assesses whether the 26 surrounding pixels, (8 in plane, 9 above and below), contain signal above threshold. All adjacent pixels above threshold are then considered to be part of the same object. Each object is assigned a unique tag. The image is then subjected to a second pass to correctly identify connected items in three-dimensional space. The volume of each object is calculated and bacterial cluster analyzed. A volume representing individual and dividing bacteria was determined, and a threshold above this value was used to identify clusters.
Plaque Assays
Plaque assays were performed essentially as previously described (56) . Cells were plated to confluence in 35 mm glass bottom plates and stimulated overnight with 200 U/ml IFN. Cells were infected at an MOI of 5x10 -4 with GFP + S.flexneri pre-treated with poly-D-lysine. Following 30 minutes of infection at 37, plates were washed twice with HBSS and overlaid with 1.5 ml DMEM without phenol red supplemented with 5% FBS and containing 25 ug/ml gentamicin, 200 U/ml IFN, 50 ug/ml carbenicillin, and 0.5% agarose. Plates were incubated for 10 minutes at room temperature before addition of 1 ml of cell culture medium without agarose. Plaques were visualized using phase contrast and fluorescence microscopy at 24 hpi, and the Feret diameter of individual plaques was determined using FIJI. For plaque assays using GBP1 KO cells complemented with pInducer-GBP1 or -GBP1 R584-586 , cells were stimulated overnight with 1 µg/ml aTc.
Titration of GBP1 Expression from Tet-Inducible Expression System and Immunoblots
GBP1 KO cells stably transduced with pInducer-GBP1 constructs were incubated overnight with cell culture medium containing the indicated concentrations of aTc. Cells were lysed in RIPA buffer containing 1X protease inhibitor cocktail (Sigma) for 5 minutes on ice. Lysates were spun for 10 minutes at maximum speed in a microcentrifuge at 4 C, then combined with an equivalent volume of 2X Laemmli Sample Buffer containing -mercaptoethanol, and incubated at 95 for 10 minutes.
Samples were run on 4-15% Mini-PROTEAN TGX gels (Bio Rad) and transferred to nitrocellulose.
Immunoblots were probed with 1:1,000 anti-GBP1 (Abcam ab131255), 1:1,000 anti-mCherry rabbit polyclonal (Abcam ab183628), or anti-GAPDH rabbit polyclonal (Abcam ab9485), followed by horseradish peroxidase-conjugated anti-rabbit IgG (Invitrogen).
Statistical Analyses. Data analysis was performed using GraphPad Prism 6.0 software. Data shown are mean  standard error of the mean (SEM) unless otherwise indicated. Statistical significance was calculated using 1-way or 2-way ANOVA or student t-test, as indicated.
Significance was defined as (****P < 0.0001; ***P < 0.001; **P < 0.01; *P < 0.05).
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